Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

566
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
566
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

64
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
64
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Variability: Analysis01:11

Variability: Analysis

158
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
158
Variation01:19

Variation

6.8K
An important characteristic of any set of data is the variation in the data. In some data sets, the data values are concentrated closely near the mean; in other data sets, the data values are more widely spread out from the mean. The most common measure of variation, or spread, is the standard deviation, which is the square root of variance.
When independent and dependent variables are plotted on a scatter plot, the slope of a line is a value that describes the rate of change between the two...
6.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Blood Never Lies: The PopPK-Based Lie Detector.

Clinical pharmacokinetics·2026
Same author

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION project.

British journal of clinical pharmacology·2026
Same author

Could a macular telangiectasia type 2-like phenotype characterize retinal JC virus infection?

AIDS (London, England)·2026

相关实验视频

Updated: Jul 16, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.6K

多变量精确差异:PK/PD模型评估的新工具

Sarah Baklouti1,2, Emmanuelle Comets3,4, Peggy Gandia1,2

  • 1Laboratoire de Pharmacocinétique et Toxicologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.

Clinical pharmacokinetics
|September 17, 2023
PubMed
概括

这项研究引入了一种评估药理动力学模型的新方法,解决了分析个体内依赖度数据的当前方法的局限性. 该方法分配了一个概率得分,以评估模型适合每个患者,有助于选择用于治疗药物监测的模型.

更多相关视频

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

相关实验视频

Last Updated: Jul 16, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.6K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

科学领域:

  • 药学指标 (Pharmacometrics) 是一个指标.
  • 药物动力学建模 药物动力学建模
  • 统计分析 统计分析

背景情况:

  • 药物动力学 (PK) 模型对于药物开发和治疗药物监测至关重要.
  • 目前的评估指标,如视觉预测检查 (VPC) 和规范预测分布错误 (NPDE),具有局限性,特别是在同一患者的依赖度数据.
  • 需要改进的方法来准确评估PK模型在复杂场景中的性能.

研究的目的:

  • 为药理动力学模型提出一种新的评估方法,该方法明确解释了个体内的度测量之间的依赖性.
  • 提供一个强大的方法来评估模型的合适性,并确定在PK模型开发中的潜在问题.
  • 为了促进治疗药物监测的适当模型的选择.

主要方法:

  • 拟议的方法分析模拟度向量的分布,以生成个别概率得分.
  • 这一分数反映了个体观察到的度来源于研究的PK模型的可能性.
  • 这些单个概率的综合分析允许对整体模型性能进行全面评估.

主要成果:

  • 该方法的有效性通过两个说明性示例来证明.
  • 该方法成功地发现了结构模型的错误规范.
  • 在数据集中有效检测出异常动力学,突出显示了该方法的灵敏度.

结论:

  • 提出了一种简单有效的方法,用于在开发过程中评估PK模型.
  • 该方法在选择治疗药物监测的最佳模型方面表现有前途.
  • 建议在更大规模上进行进一步验证,以确认该方法的广泛适用性和稳定性.